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Abstract
The two main physiological systems involved in the regulation of the stress response are the hypothalamus-pituitary-
adrenal (HPA) axis and the sympathetic nervous system (SNS). However, the interaction of these systems on the stress
response remains poorly understood. To better understand the cross-regulatory effects of the different systems involved in
stress regulation, we developed a new stress paradigm that keeps the activity of the HPA constant when exposing subjects
to psychosocial stress. Thirty healthy male participants were recruited and randomly assigned to either a dexamethasone
(DEX; n=15) or placebo (PLC; n=15) group. All subjects were instructed to take the Dexamethasone (2 mg) or Placebo pill
the night before coming to the laboratory to undergo the Trier Social Stress Task (TSST). Salivary cortisol, salivary alpha
amylase (sAA), heart rate, blood pressure and subjective stress were assessed throughout the protocol. As expected, the
DEX group presented with suppressed cortisol levels. In comparison, their heart rate was elevated by approximately ten
base points compared to the PLC group, with increases throughout the protocol and during the TSST. Neither sAA, nor
systolic or diastolic blood pressures showed significant group differences. Subjective stress levels significantly increased
from baseline, and were found to be higher before and after the TSST after DEX compared to placebo. These results
demonstrate a significant interaction between the HPA and the SNS during acute stress. The SNS activity was found to be
elevated in the presence of a suppressed HPA axis, with some further effects on subjective levels of stress. The method to
suppress the HPA prior to inducing stress was found to completely reliable, without any adverse side effects. Therefore, we
propose this paradigm as a new method to investigate the interaction of the two major stress systems in the regulation of
the stress response.
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Introduction
For several decades now, psychoendocrine stress research has
investigated the activation of the hypothalamus-pituitary-adrenal
(HPA) axis in relation health and disease. It has been well
established that psychological stress activates the HPA axis and
its end product, cortisol, has become a reliable biological
marker of the stress response [1]. Upon activation of the HPA
axis, the hypothalamus releases corticotrophin-releasing hor-
mone (CRH), which stimulates the release of adrenocorticotro-
pic hormone (ACTH) from the anterior pituitary. This in turn
triggers the adrenal cortex to release cortisol into the
bloodstream [2].
The association between HPA axis regulation and various
disease states has been studied extensively, and a dysregulation of
the stress response (either a hyper- or hypoactivity) has been
associated with a host of negative health outcomes, e.g., diabetes,
hypertension, vascular disease [3,4,5].
Theories, such as the ‘‘allostatic load theory’’ describe possible
mechanisms linking stress systems and disease. While a role of the
stress systems in causing health ailments is rarely disputed, few
studies have actually investigated the consequences of acute
manipulation of the cortisol release in response to stress on
physiological and psychological variables.
To investigate the acute stress response, one of the most
frequently used laboratory stressors is the Trier Social Stress Task
[1,6]; a combination of a free speech and mental arithmetic in
front of an audience. The typical cortisol stress response to the
TSST has been well described, with a cortisol peak occurring 20–
30 minutes after stressor onset and hormone levels returning to
baseline within sixty minutes after stress onset [1,7]. This delivery
of the cortisol stress hormone is believed to aid the organism in
dealing with the increased energy demands that the situation
requires [8].
Other systems change their activity in response to a stressor
as well. Aside from the HPA axis, the sympathetic nervous
system (SNS) is prominently involved in the stress response [9].
The result of an activation of the SNS system are changes in
heart rate, blood pressure, galvanic skin response, salivary
alpha-amylase (sAA) [10], among others. The two systems are
not equally activated in response to stress, and recent studies
demonstrate that the HPA axis response is stronger to social-
evaluative types of stress, while the SNS is stronger in response
to stressors causing anxiety and fear [8]. These measures are
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that there is a cross-talk between the two stress systems, i.e. that
they interact in relation to the perception and processing of
psychosocial stress. However, no systematic studies have looked
at this interaction - specifically what happens to one system if
the other one failed to respond has to the best of our knowledge
not been previously investigated.
The aim of the present study was thus to investigate the
interaction between the HPA and SNS systems by blocking the
acute HPA axis response and then exposing the subject to an acute
stressful situation. The research question led to the development of
a new stress paradigm: a combination of the dexamethasone
suppression test (DST) and the TSST, termed ‘‘The combined
Dexamethasone/TSST paradigm.’’
The DST is commonly used to test negative feedback inhibition
of the HPA axis. As a potent synthetic glucocorticoid (GC),
dexamethasone (DEX) primarily binds to GC receptors in the
periphery, and the pituitary [11,12,13,14,15], resulting in an
almost complete suppression of pituitary release of ACTH for
several hours, lasting into the morning following DEX adminis-
tration the evening before [12]. The lack of ACTH then leads
further to almost complete absence of cortisol since the adrenal
cortex is not stimulated. It is important to differentiate the effects
of a low to moderate administration of DEX between the brain
and the periphery. DEX does not cross the blood-brain barrier
and thus will not reach receptors above the level of the pituitary in
the central nervous system [12,16], thus depriving the CNS from
any stimulation with glucocorticoids, and causing a hypocorticoid
state. In contrast, the amounts typically used in the DST (1–2 mg)
lead to a flooding of receptors in the periphery, causing
a hypercorticoid state in the body. In the combined Dexameth-
asone/TSST paradigm, subjects are exposed to the TSST after
DEX has been given the night before, and thus this paradigm
allows to test the response of the individual to an acute and strong
stressor at the psychological level (effects on the perception of the
stressor) and the physiological level (effects on the activity of
the SNS), in the absence of an HPA axis stress response. Given the
role of the HPA system in coping with stress, and the interaction
between the different stress systems in the human organism, we
hypothesized that the blockade of a cortisol response to acute stress
will result in an increased perception of psychological stress, and
an increased activity of the SNS.
Methods
Ethics Statement
McGill University’s Faculty of Medicine Institutional Review
Board approved this protocol. All subjects provided written
informed consent prior to entering the study.
Subjects
Since this was to the best of our knowledge the first study of its
kind to investigate the interaction between the stress systems we
decided to focus our study on men, to avoid a confounding effect
of cycling menstrual hormones on the HPA and SNS systems.
Thirty healthy men between the ages of 18 and 35
(M=24.065.17) with normal body mass index
(M=22.2265.17) were recruited through classified ads. All
participants were screened over the phone for their medical
history. Subjects with medical or psychiatric conditions (e.g.
diabetes, depression, etc.) or taking medications, known to affect
endocrine function, such as glucocorticoids, were excluded.
Smokers were also excluded as smoking affects the HPA axis [1].
General Procedure
Participants were randomly assigned to either of two conditions:
(1) placebo (n=15, mean age=23.8065.20) and (2) dexametha-
sone (DEX) (n=15, mean age=22.2065.32). Two appointments
were made with each subject. The first appointment served to
explain the study procedures, complete the consent form, and to
supply the participant with the study materials: either placebo, or
2 mg DEX in the form of a tablet to be taken orally. The
experimenter then informed the subject to take the pill at bedtime
the night before the testing session at our laboratory. The second
appointment then took place at 10h00 or 10h30 a.m., the morning
after DEX administration. Participants arrived at the laboratory at
least an hour before the stress session and completed a battery of
questionnaires assessing numerous personality traits known to
affect stress reactivity including parental care [17], self-esteem
[18,19], and depressive symptomatology [20,21]. After an
additional 40-minute rest period, participants were exposed to
the TSST [1]. Participants then rested for another 40 minutes, and
were then debriefed about the nature of the study.
In this study we opted for a between subject design because of the
known habituation effects of repeated stress testing exposure.
Previous studies have shown that participants may habituate to
multiple exposures of the TSST [22,23,24], which would then
confound our effects when comparing the DEX and PLC groups.
Psychological Stress Induction
In this study, a slightly modified version of the TSST was used.
Participants were brought to a waiting room adjacent to the testing
room and instructions were read out. Subjects were instructed that
they would be doing a mock job interview and had 5 minutes to
convince a panel of behavioral experts that they were the best
candidates for the job. The experimenter introduced the panel,
informed the participants that they would be evaluating their
verbal and paraverbal skills and that their speech would be
recorded via camera for a later more in-depth analysis. Moreover,
after the 5-minutes interview, the committee would let them know
of a second task. The subjects were then given ten minutes to
prepare for their presentation (anticipation phase). In the current
study, an extra 5-minute period was inserted between the
anticipation phase and the presentation to allow the participants
to fill out additional questionnaires, including the Primary
Appraisal and Secondary Appraisal questionnaire [25], a modified
version of the Fear of Negative Evaluation Scale [26] and COPE
inventory [27].
Physiological and Endocrinological Measures
Saliva samples were collected using salivettes (Sarstedt, Quebec
City, Quebec, Canada) to assess cortisol and alpha-amylase.
Cortisol was analyzed with a time-resolved fluorescence immuno-
assay with proven reliability and validity [28]. Alpha-amylase was
analyzed via the enzyme kinetic method outlined elsewhere [29].
Blood pressure and heart rate were measured by an ambulatory
(A&D Company, Tokyo, Japan) before the TSST, and finger pulse
oximeter (Roxon, Montreal, Canada) during the TSST. Prior to
statistical analysis, readings from the finger pulse oximeter and the
sphygmomanometer were synchronized, using the latter as the
reference value. Finally, subjective stress was evaluated using a ten-
point visual analogue scales asking ‘‘How stressed do you feel right
now?’’ ranging from ‘‘not at all’’ to ‘‘extremely.’’ All measures
were assessed in 10 to 15 minute intervals throughout the protocol.
Additionally, heart rate was assessed in 1-minute intervals during
and 5-minutes post TSST. Figure 1 depicts the timing of each
sampling.
The Combined Dexamethasone/TSST Paradigm
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Serial one-way (Group) analysis of variance (ANOVAs) with
age, body mass index (BMI) and several personality factors as
dependent variables were conducted to ensure the groups did
not differ on these variables. Analyses for cortisol, alpha-
amylase, heart rate, blood pressure and subjective stress were
carried out.
To investigate the interaction and main effects of the
experimental conditions on the stress response on the cortisol
levels over time a two-factor (Time x Group) between-design
repeated ANOVA with the eight cortisol measures as dependent
variable. This analysis was repeated for alpha-amylase, heart
rate, subjective stress ratings, systolic and diastolic blood
pressure, with the eight respective values as the (repeated
measures) dependent variable. We also performed this analysis
with the fifteen one-minute heart rate measures during and after
the TSST.
In cases where assumptions of sphericity were violated, Huynh-
Feldt corrections were performed. This correction adjusts the
degrees of freedom in the ANOVA test and consequently the
significance (p) value. Additionally, post-hoc analyses using
Tukey’s Honestly Significant Difference (HSD) test were con-
ducted on significant results. This test was performed to un-
derstand the direction of the significant differences and pinpoint
exactly between which timepoints the differences were observed.’’
All statistical analyses were completed with the SPSS software
package16.0.1 for Apple OS X software version 10.5.8.
Results
The serial one-way (Group) ANOVAs revealed no significant
differences between the groups for age, BMI and any of the
personality variables (all Fs,3.03, ps.0.05). These results suggest
that both groups were comparable on these factors and that they
were unlikely to contribute to endocrinological, cardiovascular or
cognitive differences observed between the groups.
Effects of the Experimental Conditions on Salivary
Cortisol
The two-factor (Time x Group) between-design repeated
ANOVA showed a significant interaction effect of Time x Group,
F(2.07, 57.96)=8.28, p=0.001, and a main effect of Time, F(2.07,
57.96)=8.82, p,0.0001, and, as expected, a highly significant effect
of Group, F(1, 28)=91.08, p,0.0001.
To further explore the interaction and main effects, we
performed a Tukey HSD. This analysis revealed significant
differences at all timepoints between the DEX and PLC groups,
with all cortisol levels in the DEX group lower than in the PLC
group, all p,0.001.
Furthermore, in the PLC group, the Post-Hoc analysis revealed
significant differences between samples 1 through 3 (pre-TSST)
and 5 through 7 (post-TSST and recovery), indicating that the
baseline measures were lower than the other values, all p,0.001.
Sample 4 (post-TSST) was also found to be significantly lower
than samples 5 and 6 (post-TSST), all p,0.05. In contrast, no
significant differences were observed between any of the samples
in the DEX group (see Figure 2). Throughout the test, the DEX
group had cortisol levels which were at or below the sensitivity
threshold of the assay, indicating an almost complete suppression
of the HPA axis.
Effects of the Experimental Conditions on Subjective
Stress
The analysis of the subjective stress with a two-factor (Time x
Group) between-design repeated ANOVA showed a significant
interaction effect of Time x Group before the Huynh-Feldt
correction, F(7, 196)=2.357, p=0.025 and a trend post correction,
p=0.077. A significant main effect of Time was also observed,
F(3.018, 84.501)=45.227, p,0.0001, but no main effect of Group,
F(1, 28)=0.723, p.0.05.
A trend was observed at timepoint 3 and 4 between the groups,
p,0.1, where the DEX group showed higher subjective ratings.
Taken together, this set of findings suggested that there was at least
a trend for higher stress perception in the DEX group, particularly
during the exposure to the TSST. (see Figure 3).
Effects of the Experimental Conditions on Salivary Alpha-
Amylase
The analysis of the effect of the condition on the salivary alpha-
amylase conducted by the two-factor (Time x Group) between-
design repeated ANOVA solely revealed a significant main effect
of Time, F(4.41, 123.34)=12.52, p,0.001, but neither a significant
interaction effect of Time x Group, nor a main effect of Group, all
Fs,1, p.0.5, thus suggesting that the complete suppression of
HPA axis activity did not have a significant effect on sAA levels.
The Post-Hoc analysis of the Time effect revealed significant
differences, with samples being higher during the acute stress
exposure (all p,.001). These effects illustrate the increase in sAA
levels in response to the TSST. (see Figure 4).
Figure 1. Timeline of the testing procedure.
doi:10.1371/journal.pone.0038994.g001
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The two-factor (Time x Group) between-design repeated
ANOVA with the eight main heart rate measures showed
a significant interaction effect of Time x Group, F(4.28,
119.78)=3.13, p=0.015, and a main effect of Time, F(4.28,
119.78)=25.88, p,0.0001, and Group, F(1, 28)=9.23, p=0.005.
Post-hoc tests indicated that while both groups showed an increase
of heart rate during the acute stress induction (all p,.001), the
DEX group was significantly higher than the PLC group, in all
samples (all p,0.0012), by about ten beats per minute (see
Figure 5).
Furthermore, the two-factor (Time x Group) between-design
repeated ANOVA with the fifteen 1-minute interval heart rate
measures confirmed a significant interaction effect of Time x
Group, F(6.94, 194.44)=2.03, p=0.053, and a main effect of Time,
F(6.94, 194.44)=12.85, p=0.0001, and Group, F(1, 28)=11.08,
p=0.003.
Here, post-hoc analysis revealed that there was a further
increase in heart rate in the middle of the stress session as
compared to the recovery period, and that samples from the DEX
group were found to be significantly higher than the PLC group
throughout (all p,.05).
Taken together, these effects illustrate that one main effect of
suppressing DEX was a higher heart rate throughout the
experiment, with higher levels at the beginning and throughout
the experiment, but in addition higher levels also at the peak stress
period during the TSST (see Figure 6).
Effects of the Experimental Conditions on Blood Pressure
The analysis of the systolic and diastolic blood pressure with
the two-factor (Time x Group) between-design repeated AN-
OVA, did not reveal a significant interaction effect of Time x
Group or main effect of Group for both variables, all Fs,1.11,
all ps.0.3. However the ANOVAs did show a significant Time
effect for both variables, F(4.99, 139.69)=21.32, p,0.0001, for the
Figure 2. Effects of the TSST on the cortisol release in relation of the two experimental conditions: dexamethasone (n=15) and
placebo (n=15).
doi:10.1371/journal.pone.0038994.g002
Figure 3. Effects of the TSST on the subjective stress ratings in relation of the two experimental conditions: dexamethasone (n=15)
and placebo (n=15).
doi:10.1371/journal.pone.0038994.g003
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the diastolic blood pressure.
The Post Hoc analysis of the Time effect of the systolic blood
pressure revealed that systolic blood pressure levels were higher
during the acute stress exposure (all p,0.02). The post hoc
analysis for the diastolic blood pressure Time effect showed a peak
directly after the TSST exposure, when compared to baseline and
recovery (all p,0.005 (see Figure 7 and 8).
Discussion
The goal of the present study was investigate the effects of
suppressing the HPA axis system in the presence of an acute
stressor on blood pressure, heart rate, alpha-amylase, and the
subjective experience of stress. In order to do so, we applied an
HPA axis suppressant prior to administering acute psychosocial
stress. The combined Dexamethasone/TSST paradigm was
successful in investigating the effects of HPA axis suppression on
salivary alpha-amylase, subjective stress, heart rate and blood
pressure. To the best of our knowledge no previous studies have
investigated the effect of suppressing the HPA axis response during
an acute psychological stress on levels of sAA, heart rate, blood
pressure and subjective stress.
While the DEX group had cortisol levels at or below the
detection threshold of the assay, both groups showed an increase
in subjective stress ratings with a rise in response to the
anticipation period, and the actual TSST, this result being in line
with Hellhammer and Schubert [30], who also recorded subjective
stress during the TSST. The peak level of subjective stress was
close to peak levels in sAA, heart rate and blood pressure
responses, suggesting that the subjective stress rating is more
closely associated with the activity of the SNS system rather than
the HPA. This is best demonstrated in the DEX group, which, in
the absence of any HPA response showed a trend for higher
subjective stress responses, in line with a higher heart rate. One
possible explanation for this is the fact that the changes of the SNS
are tangible, for example an increase in heart rate, while there are
no known perceptible physiological changes related to a change in
cortisol secretion.
The analysis of sAA showed a significant effect of Time with
a typical response, peaking 10-minutes after onset of the stressor
[31,32], similar to the systolic and diastolic blood pressure analysis.
Figure 4. Effects of the TSST on the salivary alpha-amylase in relation of the two experimental conditions: dexamethasone (n=15)
and placebo (n=15).
doi:10.1371/journal.pone.0038994.g004
Figure 5. Effects of the TSST on the heart rate in relation of the two experimental conditions: dexamethasone (n=15) and placebo
(n=15).
doi:10.1371/journal.pone.0038994.g005
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safe to conclude that the presence or absence of cortisol did not
affect either sAA or blood pressure. When interpreting a non-
significant result it is important to consider the power to find an
effect in the study sample if it was indeed existing in the
population. Thus, a post-hoc power analysis was conducted and
demonstrated that, in this study, when assuming a medium effect
size (f
2=0.25) we had a power of at least (1-b)=0.96. This result
dramatically decreased to (1-b)=0.29 when assuming a small
effect size (f
2=0.1) [33].
The most significant effect from HPA axis suppression, and thus
from the entire study, was found in the change of heart beat
throughout the experiment. The results showed significantly
higher beats per minute in the DEX group compared to the
PLC group, from the beginning of our heart rate recording,
throughout the entire experiment: before, during and after the
TSST. The effect was rather stronger, with a ten base point
difference between the experimental groups.
There are a number of possible explanations for this effect. For
one, it may be due to the central hypocortisol state created by the
DST. The lack of negative feedback in the paraventricular nucleus
of the hypothalamus will likely result in a CRH surge. It has been
shown that there is a CRH-induced sympathetic activation,
resulting in increased heart rate, blood pressure and glucose
[34,35]. Morphologically, CRH-secreting neurons from the
hypothalamus project to the hindbrain and vice-versa. Also, the
HPA and SNS seem to activate one another in a feed forward
mechanism, via the CRH and locus coeruleus/norepinephrine
(LC/NE) connection. Moreover, it has been shown that NE
potentiates the release of CRH and application of CRH to the LC
neurons increases its firing rate, further confirming the physiolog-
ical link between the two systems (for review see [34]). Therefore,
the hypocortisolemic state of the brain may be the cause for the
elevated heart rate via a CRH surge, and the PVN and LC
connection. Unfortunately, in the absence of any CRH measures
this explanation must remain speculatory. Additionally, heart rate
is mediated through the balance of the SNS and parasympathetic
Figure 6. Effects of the TSST on the heart rate in 1-minute intervals during and 5 minutes post-TSST in relation of the two
experimental conditions: dexamethasone (n=15) and placebo (n=15).
doi:10.1371/journal.pone.0038994.g006
Figure 7. Effects of the TSST on the systolic blood pressure in relation of the two experimental conditions: dexamethasone (n=15)
and placebo (n=15).
doi:10.1371/journal.pone.0038994.g007
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the parasympathetic nervous system could also be hypothesized.’’
A second explanation for the elevated heart rate could be the
direct effect of dexamethasone on peripheral tissue involved in
cardiovascular regulation. Glucocorticoid (GC) receptors are
found throughout the body including skin, lungs and heart [36].
It has been long recognized that steroids have an effect on
cardiovascular function, and DEX has been shown to directly
affect the beating of myocardial cells [36]. GCs also affect
vasoconstriction and, interestingly, DEX also potentiates the
pressor response to NE [37]. It must be noted that these effects do
not directly alter heart rate, but it shows an involvement of GCs in
cardiovascular regulation. As a third possible explanation, the
higher heart rate found in the dexamethasone group may be due
to a combination of both the hypo- and hyper-cortisol state in the
CNS and the periphery working together, as the central
hypocortisol state results in increased NE release and the
peripheral hypercortisol state then could potentiate this effect.
Maheu et. al. (2005) also manipulated the HPA axis using
metyrapone and observed an elevated heart rate pre and post-
TSST. However, one must note the differential effects of
metyrapone and DEX. As previsouly stated, DEX creates 2
states: a central hypocortisol state and a peripheral hypercortisol
state, while metyrapone results in an overall hypocortisol state as it
prevents the production of cortisol altogether. As these manipula-
tions both result in an elevated heart rate, the most likely
explanation for this would be their common effect on the central
hypocortisol state. Even though, any hypotheses on the link
between dexamethasone and cardiovascular effects have to be
considered speculatory, as the exact mechanisms between the two
are still unknown.’’
Yet, we must note that indices of higher SNS activity found in
the experimental group compared to the control group were
restricted to heart rate, and not observed for our other SNS
measures. The lack of group difference observed for the sAA
measures may be explained by recent data suggesting that it is not
a specific marker of SNS activity, but rather an overall measure of
changes in the autonomic nervous system [38].
Overall, these findings may be explained by the fact that all of
the employed measures for SNS were indirect. Therefore, effects
on these indirect SNS markers may have been less consistent,
resulting in smaller effect sizes, and thus harder to detect
compared to measuring the SNS more directly (for example,
through epinephrine and norepinephrine levels, which are
however notoriously difficult to obtain by themselves). Previous
literature has shown that blood pressure and heart rate changes do
not occur always in parallel and that even when pharmacologically
manipulating the SNS directly, changes are not always observed in
all of these indirect measures. For example, after propranolol
administration, a beta-blocker, Maheu et. al. [39] observed no
significant differences in heart rate and diastolic blood pressure
after the TSST, when compared to the placebo group. However,
they observed significant lower systolic blood pressure. These
findings demonstrate that even when directly affecting the SNS
not all indirect biomarkers will show change. Similarly, sAA may
not be a specific marker of SNS activity, but rather an overall
measure of change in the autonomic nervous system, further
confounded by flow rate, as already mentioned. Moreover, it has
been shown that a chronically elevated heart rate may cause
vasoconstriction, arterial stiffening and insulin resistance, all
resulting in hypertension [40]. However in this study, the elevated
heart rate state may have been too acute and could explain why
the effect is not reflected in the blood pressure measures. The low
and single dose of DEX may also explain why we do not observe
a significant blood pressure difference between the groups, as
Brotman et. al. [41] observed an elevated blood pressure after a 5
day, 3 mg twice a day regiment of dexamethasone. Nonetheless,
despite the lack of group difference, both variables did show
a typical pattern of stress reactivity.
Taken together, the combination of Dexamethasone with the
TSST paradigm allowed us to investigate the interaction between
the various stress systems by suppressing the HPA. This task may
be used to further examine and disentangle the contribution of
each of these systems in disorders involving a dysregulation of
either of these systems, such as chronic stress, or the metabolic
syndrome. In conditions where one of the available physiological
stress systems is chronically changed, it would be very informative
to investigate what effect such a change has on the complimentary
stress response systems. We suggest that the DEX/TSST
paradigm will allow you to that. In addition, other known effects
of stress like memory, cognition, attention and decision making,
could also benefit from the application of this paradigm to
differentiate the contribution of the physiological versus the
psychological systems in these previously observed effects. Future
studies could also expand this line of research by performing the
reverse test, i.e. by suppressing the SNS to investigate the effect on
Figure 8. Effects of the TSST on the diastolic blood pressure in relation of the two experimental conditions: dexamethasone (n=15)
and placebo (n=15).
doi:10.1371/journal.pone.0038994.g008
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propranolol; this study is currently being conducted in our
laboratory.
In conclusion, this study demonstrated that the SNS clearly
responded differentially to a standardized stress paradigm in the
presence or absence of an HPA axis response. When the HPA was
suppressed, a significantly higher heart rate response to the TSST
occurred, indicating an inverse relationship between the two
systems, where SNS activity may be elevated in the presence of
a blunted HPA axis response. An overactive SNS has previously
been linked to hypertension, atherosclerosis, increased cardiovas-
cular risk and events [40,42]. Knowing that several psychopathol-
ogies, such as depression and burnout, are linked with the
dysregulation of the HPA, this finding may further have critical
health implications. It is unclear whether the interaction between
the HPA and the SNS is continuous, i.e. whether a more subtle
blunting of the HPA would similarly result in a more slightly
elevated heart rate response. However, given the high prevalence
of cardiovascular diseases in the developed world, this clearly
deserves further investigation.
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